☰

Jason S. Knight, Ph.D. - Publications

Affiliations: 
2005 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Microbiology Biology, Virology Biology
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Knight JS, Lan K, Subramanian C, Robertson ES. Correction for Knight et al., "Epstein-Barr Virus Nuclear Antigen 3C Recruits Histone Deacetylase Activity and Associates with the Corepressors mSin3A and NCoR in Human B-Cell Lines". Journal of Virology. 95: e0076521. PMID 34251281 DOI: 10.1128/JVI.00765-21  0.48
2020 Zuo Y, Yalavarthi S, Gockman K, Madison JA, Gudjonsson JE, Kahlenberg JM, McCune WJ, Bockenstedt PL, Karp DR, Knight JS. Anti-NET antibodies and impaired NET degradation in antiphospholipid syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32729667 DOI: 10.1002/Art.41460  0.343
2020 Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, Blair CN, Weber A, Barnes BJ, Egeblad M, Woods RJ, Kanthi Y, Knight JS. Neutrophil extracellular traps in COVID-19. Jci Insight. PMID 32329756 DOI: 10.1172/Jci.Insight.138999  0.33
2020 Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daßler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M, Looney MR, McAllister F, Rayes R, Renaud S, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. The Journal of Experimental Medicine. 217. PMID 32302401 DOI: 10.1084/Jem.20200652  0.309
2020 Zuo Y, Shi H, Li C, Knight JS. Antiphospholipid syndrome: a clinical perspective. Chinese Medical Journal. PMID 32265421 DOI: 10.1097/Cm9.0000000000000705  0.314
2019 Weerappuli PD, Louttit C, Kojima T, Brennan L, Yalavarthi S, Xu Y, Ochyl LJ, Maeda ML, Kim HS, Knight JS, Takayama S, Moon JJ. Extracellular Trap-Mimicking DNA-Histone Mesostructures Synergistically Activate Dendritic Cells. Advanced Healthcare Materials. e1900926. PMID 31614077 DOI: 10.1002/Adhm.201900926  0.305
2019 Sule G, Kelley WJ, Gockman K, Yalavarthi S, Vreede AP, Banka AL, Bockenstedt PL, Eniola-Adefeso O, Knight JS. Increased adhesive potential of antiphospholipid syndrome neutrophils mediated by beta-2 integrin Mac-1. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31353826 DOI: 10.1002/Art.41057  0.319
2019 Ali RA, Gandhi AA, Meng H, Yalavarthi S, Vreede AP, Estes SK, Palmer OR, Bockenstedt PL, Pinsky DJ, Greve JM, Diaz JA, Kanthi Y, Knight JS. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nature Communications. 10: 1916. PMID 31015489 DOI: 10.1038/S41467-019-09801-X  0.305
2018 Liu Y, Carmona-Rivera C, Moore E, Seto NL, Knight JS, Pryor M, Yang ZH, Hemmers S, Remaley AT, Mowen KA, Kaplan MJ. Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis. Frontiers in Immunology. 9: 1680. PMID 30140264 DOI: 10.3389/Fimmu.2018.01680  0.307
2017 Knight JS, Meng H, Coit P, Yalavarthi S, Sule G, Gandhi AA, Grenn RC, Mazza LF, Ali RA, Renauer P, Wren JD, Bockenstedt PL, Wang H, Eitzman DT, Sawalha AH. Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target. Jci Insight. 2. PMID 28931754 DOI: 10.1172/Jci.Insight.93897  0.354
2017 Mor-Vaknin N, Saha A, Legendre M, Carmona-Rivera C, Amin MA, Rabquer BJ, Gonzales-Hernandez MJ, Jorns J, Mohan S, Yalavarthi S, Pai DA, Angevine K, Almburg SJ, Knight JS, Adams BS, et al. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. Nature Communications. 8: 14252. PMID 28165452 DOI: 10.1038/Ncomms14252  0.315
2016 Kazzaz NM, Sule G, Knight JS. Intercellular Interactions as Regulators of NETosis. Frontiers in Immunology. 7: 453. PMID 27895638 DOI: 10.3389/Fimmu.2016.00453  0.308
2016 Meng H, Yalavarthi S, Kanthi Y, Mazza LF, Elfline MA, Luke CE, Pinsky DJ, Henke PK, Knight JS. In vivo role of neutrophil extracellular traps in antiphospholipid antibody-mediated venous thrombosis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27696751 DOI: 10.1002/Art.39938  0.333
2015 Rao AN, Kazzaz NM, Knight JS. Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? World Journal of Cardiology. 7: 829-42. PMID 26730289 DOI: 10.4330/Wjc.V7.I12.829  0.338
2015 Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C, Hernández-Ramírez D, Bockenstedt PL, Liaw PC, Cabral AR, Knight JS. Antiphospholipid antibodies promote the release of neutrophil extracellular traps: A new mechanism of thrombosis in the antiphospholipid syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26097119 DOI: 10.1002/Art.39247  0.33
2014 Palanichamy A, Bauer JW, Yalavarthi S, Meednu N, Barnard J, Owen T, Cistrone C, Bird A, Rabinovich A, Nevarez S, Knight JS, Dedrick R, Rosenberg A, Wei C, Rangel-Moreno J, et al. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. Journal of Immunology (Baltimore, Md. : 1950). 192: 906-18. PMID 24379124 DOI: 10.4049/Jimmunol.1302112  0.341
2013 Knight JS, Zhao W, Luo W, Subramanian V, O'Dell AA, Yalavarthi S, Hodgin JB, Eitzman DT, Thompson PR, Kaplan MJ. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. The Journal of Clinical Investigation. 123: 2981-93. PMID 23722903 DOI: 10.1172/Jci67390  0.34
2012 Knight JS, Carmona-Rivera C, Kaplan MJ. Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases. Frontiers in Immunology. 3: 380. PMID 23248629 DOI: 10.3389/Fimmu.2012.00380  0.317
2009 Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology. 388: 236-47. PMID 19394062 DOI: 10.1016/J.Virol.2009.03.027  0.556
2008 Murakami M, Meneses PI, Knight JS, Lan K, Kaul R, Verma SC, Robertson ES. Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1. International Journal of Cancer. Journal International Du Cancer. 123: 500-10. PMID 18470881 DOI: 10.1002/Ijc.23568  0.511
2006 Cai QL, Knight JS, Verma SC, Zald P, Robertson ES. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. Plos Pathogens. 2: e116. PMID 17069461 DOI: 10.1371/Journal.Ppat.0020116  0.566
2006 Knight JS, Lan K, Bajaj B, Sharma N, Tsai DE, Robertson ES. A peptide-based inhibitor for prevention of B cell hyperproliferation induced by Epstein-Barr virus. Virology. 354: 207-14. PMID 16876848 DOI: 10.1016/J.Virol.2006.06.034  0.554
2006 Sharma N, Knight JS, Robertson ES. Conserved cell cycle regulatory properties within the amino terminal domain of the Epstein-Barr virus nuclear antigen 3C. Virology. 346: 379-84. PMID 16364389 DOI: 10.1016/J.Virol.2005.11.023  0.572
2005 Knight JS, Sharma N, Robertson ES. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proceedings of the National Academy of Sciences of the United States of America. 102: 18562-6. PMID 16352731 DOI: 10.1073/Pnas.0503886102  0.59
2005 Kuppers DA, Lan K, Knight JS, Robertson ES. Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1. Journal of Virology. 79: 9714-24. PMID 16014933 DOI: 10.1128/Jvi.79.15.9714-9724.2005  0.537
2005 Knight JS, Sharma N, Robertson ES. SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Molecular and Cellular Biology. 25: 1749-63. PMID 15713632 DOI: 10.1128/Mcb.25.5.1749-1763.2005  0.577
2005 Knight JS, Verma SC, Lan K, Robertson ES. Molecular genetics of herpesviruses: a recombinant technology approach. Methods in Molecular Biology (Clifton, N.J.). 292: 333-52. PMID 15507719 DOI: 10.1385/1-59259-848-X:333  0.498
2004 Knight JS, Sharma N, Kalman DE, Robertson ES. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells. Journal of Virology. 78: 12857-67. PMID 15542638 DOI: 10.1128/Jvi.78.23.12857-12867.2004  0.549
2004 Knight JS, Robertson ES. Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity. Journal of Virology. 78: 1981-91. PMID 14747563 DOI: 10.1128/Jvi.78.4.1981-1991.2004  0.575
2003 Knight JS, Lan K, Subramanian C, Robertson ES. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. Journal of Virology. 77: 4261-72. PMID 12634383 DOI: 10.1128/Jvi.77.7.4261-4272.2003  0.574
2002 Subramanian C, Knight JS, Robertson ES. The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration. Frontiers in Bioscience : a Journal and Virtual Library. 7: d704-16. PMID 11861219 DOI: 10.2741/Subraman  0.583
2001 Knight JS, Cotter MA, Robertson ES. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter. The Journal of Biological Chemistry. 276: 22971-8. PMID 11313352 DOI: 10.1074/Jbc.M101890200  0.667
Show low-probability matches.